scholarly journals Recruitment and retention of participants in a pragmatic randomized intervention trial at three community health clinics: Results and lessons learned

2013 ◽  
Vol 13 (1) ◽  
Author(s):  
Erica T Warner ◽  
Russell E Glasgow ◽  
Karen M Emmons ◽  
Gary G Bennett ◽  
Sandy Askew ◽  
...  
JAMA ◽  
1968 ◽  
Vol 203 (10) ◽  
pp. 902-903
Author(s):  
E. M. Pattison

2017 ◽  
Vol 4 ◽  
pp. 233339281773452 ◽  
Author(s):  
Praise O. Iyiewuare ◽  
Colleen McCullough ◽  
Allison Ober ◽  
Kirsten Becker ◽  
Karen Osilla ◽  
...  

Introduction: Community health clinics (CHCs) are an opportune setting to identify and treat substance misuse. This study assessed the characteristics of patients who presented to a CHC with substance misuse. Methods: Personnel at a large CHC administered a 5-question screener to patients between June 3, 2014, and January 15, 2016, to assess past 3-month alcohol use, prescription opioid misuse, or illicit drug use. We stratified screen-positive patients into 4 diagnostic groups: (1) probable alcohol use disorder (AUD) and no comorbid opioid use disorder (OUD); (2) probable heroin use disorder; (3) probable prescription OUD, with or without comorbid AUD; and (4) no probable substance use disorder. We describe substance use and mental health characteristics of screen-positive patients and compare the characteristics of patients in the diagnostic groups. Results: Compared to the clinic population, screen-positive patients (N = 733) included more males ( P < .0001) and had a higher prevalence of probable bipolar disorder ( P < .0001) and schizophrenia ( P < .0001). Eighty-seven percent of screen-positive patients had probable AUD or OUD; only 7% were currently receiving substance use treatment. The prescription opioid and heroin groups had higher rates of past bipolar disorder and consequences of mental health conditions than the alcohol only or no diagnosis groups ( P < .0001). Conclusions: Patients presenting to CHCs who screen positive for alcohol or opioid misuse have a high likelihood of having an AUD or OUD, with or without a comorbid serious mental illness. Community health clinics offering substance use treatment may be an important resource for addressing unmet need for substance use treatment and comorbid mental illness.


2016 ◽  
Vol 23 (3) ◽  
pp. 287-308 ◽  
Author(s):  
Melissa A. Rodgers ◽  
Jeane Ann Grisso ◽  
Paul Crits-Christoph ◽  
Karin V. Rhodes

Community health workers (CHWs) provide peer support in diverse health care settings, but few studies have evaluated CHW interventions for intimate partner violence (IPV). We assessed the feasibility, acceptability, and safety of CHW outreach in four urban community health clinics and characterized the experiences and barriers to providing safe and effective services for women experiencing IPV. CHWs successfully enrolled and engaged IPV victims, who indicated satisfaction and increased safety with program participation. However, complex psychosocial barriers prevented many from achieving safety and security. More work is needed to assess the impact of well-integrated IPV-trained CHWs in primary care medical homes.


JAMA ◽  
1968 ◽  
Vol 203 (10) ◽  
pp. 902
Author(s):  
E. Mansell Pattison

2016 ◽  
Vol 40 (3) ◽  
pp. 302-309 ◽  
Author(s):  
Connie L. Arnold ◽  
Alfred Rademaker ◽  
Michael S. Wolf ◽  
Dachao Liu ◽  
Jill Hancock ◽  
...  

Author(s):  
Ted Lankester

This chapter explores how to set up and develop community health clinics which not only treat illness but become a focus for health promotion and community involvement. It encourages programmes to use or strengthen existing primary health centres or health posts and to work in collaboration with the government. It discusses types of clinic, who might use the clinic, and clinic capacity and location. It works through practical aspects such as when the clinic should start, centre design, setting up clinic stations, and keeping and transferring records. It describes systems of payment, affordability, and the welcome and affirmation of those attending. It describes referral systems and preparing for serious illness and accidents. It mentions the value of mobile clinics as an integral part of a community-based system.


2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Allison J. Ober ◽  
Sae Takada ◽  
Deborah Zajdman ◽  
Ivy Todd ◽  
Tamara Horwich ◽  
...  

Abstract Background Cardiovascular disease (CVD) is a major cause of morbidity and mortality among people living with HIV (PLWH), but statin therapy, safe and effective for PLWH, is under-prescribed. This study examined clinic leadership and provider perceptions of factors associated with statin prescribing for PLWH receiving care in eight community health clinics across Los Angeles, California. Methods We conducted semi-structured telephone interviews with clinic leadership and providers across community health clinics participating in a larger study (INSPIRE) aimed at improving statin prescribing through education and feedback. Clinics included federally qualified health centers (N = 5), community clinics (N = 1) and county-run ambulatory care clinics (N = 2). Leadership and providers enrolled in INSPIRE (N = 39) were invited to participate in an interview. We used the Consolidated Framework for Implementation Research (CFIR) to structure our interview guide and analysis. We used standard qualitative content analysis methods to identify themes within CFIR categories; we also assessed current CVD risk assessment and statin-prescribing practices. Results Participants were clinic leaders (n = 6), primary care physicians with and without an HIV specialization (N = 6, N = 6, respectively), infectious diseases specialists (N = 12), nurse practitioners, physician assistants and registered nurses (N = 7). Ninety-five percent of providers from INSPIRE participated in an interview. We found that CVD risk assessment for PLWH is standard practice but that there is variation in risk assessment practices and that providers are unsure whether or how to adjust the risk threshold to account for HIV. Time, clinic and patient priorities impede ability to conduct CVD risk assessment with PLWH. Conclusions Providers desire more data and standard practice guidance on prescribing statins for PLWH, including estimates of the effect of HIV on CVD, how to adjust the CVD risk threshold to account for HIV, which statins are best for people on antiretroviral therapy and on shared decision-making around prescribing statins to PLWH. While CVD risk assessment and statin prescribing fits within the mission and workflow of primary care, clinics may need to emphasize CVD risk assessment and statins as priorities in order to improve uptake.


2009 ◽  
Vol 60 (4) ◽  
pp. 505-511 ◽  
Author(s):  
Meg Cristofalo ◽  
Doris Boutain ◽  
Trevor J. Schraufnagel ◽  
Kristin Bumgardner ◽  
Doug Zatzick ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document